FIRST Clinical Drug Testing for ARPKD/CHF
Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease. by Sweeney WE, Frost P, Avner ED Renal cystic diseases encompass a broad group of disorders with variable phenotypic expression. The term polycystic kidney disease (PKD) explicitly refers to two genetically defined renal cystic diseases: Autosomal recessive polycystic kidney [&hellip
